Speaker :

Dr. Aditya Murali, Medical Oncologist, Bangalore

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Author: Shanu Modi 

Citation: N Engl J Med 2020; 382:610-621

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase IB Study

Author: Shanu Modi 

Citation: J Clin Oncol. 2020 Jun 10;38(17):1887-1896

CNS metastases in HER2-positive metastatic breast cancer treated with  trastuzumab deruxtecan: DESTINY-Breast01 subgroup analyses

Author: Guy Jerusalem 

Citation: Annals of Oncology (2020) 31 (suppl_2): S62-S82

10.1016/annonc/annoc122x